Journal Report

MELANOMA RESEARCH

Download PDF
Journal Information
Journal Title
MELANOMA RESEARCH
Publisher
LIPPINCOTT WILLIAMS & WILKINS
ISSN
0960-8931
E-ISSN
1473-5636
Database
Clarivate
Domain
Health Sciences, Life Sciences, Physical Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Impact of bone metastases on outcomes in patients with metastatic melanoma treated with immune checkpoint inhibitors
Jessica R. Poliwoda, Kevin Du, Rossanna C. Pezo
2026-10-29
BRAF wild-type metastatic melanoma arising in a congenital melanocytic nevus initially reported as melanoma in situ, 4 years after negative sentinel lymph node biopsy: a case report and literature review
Hadi Khalil Abdulla Al-Ajmi, Shady Sabry Salama
2026-10-29
Endothelial protein C receptor expression as a marker of reduced metastatic risk in primary melanoma
Takayuki Fusumae, Takeru Funakoshi, Ikuko Hirai et al.
2026-10-28 Vol. 36 Issue 6 Pages 505-514
Treatment discontinuation after complete response to BRAF/MEK inhibition in metastatic melanoma: long-term clinical outcomes from a single institution
Maja Ivanova, Igor Stojkovski, Violeta Klisarovska
2026-10-28 Vol. 36 Issue 6 Pages 540-543
Melanoma diagnosis by artificial intelligence in general practice: from artifacts in imaging to equitable implementation and clinical generalizability
Chanthini Kanagaraj Muthu-Pandian
2026-10-28 Vol. 36 Issue 6 Pages 589-590
Tele-expertise in melanoma: what about the lesions that never reach the dermatologist?
Vincenzo De Giorgi, Giovanni Cecchi, Gabriella Perillo et al.
2026-10-28 Vol. 36 Issue 6 Pages 591-592
Melanoma screening beyond balanced datasets: the need for real-world validation
Vincenzo De Giorgi, Gabriella Perillo, Giovanni Cecchi et al.
2026-10-28 Vol. 36 Issue 6 Pages 590-591
Targeted BRAF/MEK inhibition as a salvage therapy for patients with metastatic melanoma harboring a BRAF L597R mutation: two case reports and review of the literature
Andrew Moufarrej, Sarah Biermann, Robin Springer et al.
2026-10-28 Vol. 36 Issue 6 Pages 579-583
Dissociation between systemic inflammatory markers and the tumor microenvironment in predicting sentinel lymph node metastasis in cutaneous melanoma
Nilay Duman, Aslıhan Özel, Damla Değirmenci et al.
2026-10-28 Vol. 36 Issue 6 Pages 544-549
Earlier is not necessarily actionable: the clinical dilemma of circulating tumor DNA-detected molecular relapse in resected melanoma
Lucio Buffoni
2026-10-28 Vol. 36 Issue 6 Pages 592-593
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 2, 2026 18:30